LobbyingMahzi Therapeutics lobbying by quarter
Mahzi Therapeutics's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2026; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Mahzi Therapeutics
- Latest quarter
- $0
- Q2 2026 · 1 reports
- Last 12 months
- $20K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $20K | 1 |
| Q2 2026 | $0 | 1 |
Policy issues the reports name
- Health issues1 reports
- Medical research and clinical labs1 reports
- Science and technology1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The KPM Group DC | $20K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | The KPM Group DC | Under $5,000 |
| 04/20for Q1 | The KPM Group DC | $20K |
| 03/30for Q1 | The KPM Group DC | Under $5,000 |